Media Room
10 May 2017
Posijet®: The history of an exemplary partnership presented at the JFMN congress
The latest version of Posijet®, a mobile unit for the preparation and injection of high-energy radiopharmaceuticals, has become the compact and mobile reference solution for nuclear medicine services. Designed by Lemer Pax, optimized in collaboration with the Confluent Group, Posijet® V3 is a great success in France and internationally.
14 March 2017
Posijet®, solutions you can trust
For Lemer Pax, Posijet® is a symbol of the great technological progress we have made and the close partnerships we continue to forge with healthcare professionals.
3 February 2017
Epijet® on track for success
At the most recent congress of the Spanish Epilepsy Society and at the EANM, Epijet® has attracted much interest from nuclear medicine specialists and neurologists.
10 November 2016
Orano Med and Lemer Pax: a partnership built to last
A consortium committed to demonstrating the benefits of Lead-212 for cancer treatment, and launching production on an industrial scale.
25 October 2016
Lemer Pax and Medisystem, working hand-in-hand
Closer collaboration, symbiosis and an expanded range of solutions!
9 May 2016
New nuclear medicine system: Lemer Pax Partners with Confluent Group
After being operational partners for several years, Confluent and Lemer Pax have decided to officialise their partnership. Lemer Pax is providing the hospital with the new generation Posijet® radiopharmaceutical injection system for 3 months. The test phase will demonstrate the...
20 March 2016
Innovation rewarded
Lemer Pax is the first recipient of the new innovation funding mechanism “Pays de la Loire Innovation Fund – Investments for the Future Programme”. We received a grant to develop a new innovative, ecological, radiation protection material. The Pays de la Loire...
10 February 2016
Moltek, Lemer Pax’s partner for the middle East and central Asia
Thanks to the excellent and long-standing relations between Pierre-Marie Lemer and Can Zafer Aksoy, Lemer Pax has signed a three-year distribution agreement with Moltek, an Istanbul company and leader in the fi eld of nuclear medicine. This agreement covers the distribution...
20 November 2015
Posijet®: always closer to your expectations, always easier, always reliable!
The new Posijet® of Lemer Pax is a real compendium of innovations for radiation protection and administration of radiopharmaceuticals in nuclear medicine. Following the release of the Easypet®, new automated preparation system of high energy radiopharmaceutical, installed in Versailles in...
23 June 2015
It’s Versailles!
Lemer Pax has just installed radiation protection equipment in the new nuclear medicine department of Versailles hospital. The equipment installed includes an Easypet, “giving this versatile and automatic fractionation unit a wonderful showcase in the Paris region” underlines Antoine Moret de...
7 April 2015
With CERN Medicis, Lemer Pax is part of a European partnership
CERN Medicis is a research institute that will be using a proton beam and an innovative mass separation process for radio isotopes for medical applications around the world. This project is devoted to nuclear medicine. In collaboration with CERN (European...
17 October 2014
October in Gothenburg during the EANM congress
The 2014 edition of the EANM (European Association of Nuclear Medicine) was an excellent year for Lemer Pax. Contacts made on the booth set the tone for the four days of the congress which saw demonstrations of the Posijet® and the...
4 July 2014
QuantiCardi® at the heart of “Isotop Valley®”
The QuantiCardi® project has been accredited by “Atlanpole Biothérapies” as part of the cluster’s radiopharmaceuticals theme. It targets the preindustrial development of innovative devices dedicated to cardiac imaging using Positron Emission Tomography (PET). This project, funded by the 12th IMF...
19 June 2014
Strengthening of the French-Japanese partnership for Lemer Pax
Last January, Valérie Chevreul, Managing Director, and Pierre-Marie Lemer, CEO at Lemer Pax, have completed a sales mission in Japan. This trip was an opportunity to forge closer links with our Japanese partners in nuclear protection, and reach out to a...
26 October 2013
EANM 2013: The city of Lyon boosted the EANM
The European congress on nuclear medicine – EANM – has allowed Lemer Pax to reinforce its partnership with ISOTOP4LIFE, Chelatec, Nucsan and Keosys. The meetings organised on the stand have demonstrated the great interest that the main market players have...
1 October 2013
ISOTOP4LIFE a consortium dedicated to personalised medical care
“ISOTOP4LIFE is currently Europe’s most extensive and integrated network in the radioapharmacy sector“, in the opinion of Jean-François Gestin (Director of Research at the INSERM (French Institute of Health and Medical Research) and co-founder of Chelatec). The structuring of the...
France
